Yucheng Health Technology

Yucheng Health Technology is a Beijing-based biotechnology company specializing in AI-driven drug discovery. Founded in 2021, the company leverages a proprietary platform that integrates deep learning with physics-based simulations to accelerate the design and optimization of novel small molecule therapeutics. Their primary focus is on addressing unmet medical needs in oncology and other complex disease areas by predicting molecular properties and binding affinities with high precision. By combining computational chemistry with biological data, Yucheng Health aims to significantly reduce the time and cost associated with traditional pharmaceutical R&D. The company is backed by prominent venture capital firms and is actively developing an internal pipeline while pursuing strategic partnerships.